NEOBEE M-5 was developed in the 1950s for use in products to treat patients with fat malabsorption syndrome. Derived from the esterification of capric and caprylic fatty acids with glycerin, Neobee M-5 follows a unique metabolic pathway.

Unlike typical long chain triglycerides that travel through the lymphatic system, the ingredient travels directly to the liver. As a result, it is metabolized in 1/8 the time of long chain triacyglycerides and does not accumulate as fat in the body.

For these reasons, Neobee M-5 finds use in sports nutrition products and healthy cooking oils.

Stepan Co., James Butterwick, 201-712-7642, jbutterwick@stepan.com